UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Prostate cancer screening： and yet it moves

Asian journal of andrology, 2015-05, Vol.17 (3), p.437-438

2015

Volltextzugriff (PDF)

Screening and Prostate-Cancer Mortality in a Randomized European Study

The New England journal of medicine, 2009-03, Vol.360 (13), p.1320-1328

2009

Volltextzugriff (PDF)

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

The Lancet (British edition), 2017-10, Vol.390 (10104), p.1747-1757

2017

Volltextzugriff (PDF)

Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors

Brain research bulletin, 2024-06, Vol.212, p.110955-110955, Article 110955

2024

Volltextzugriff (PDF)

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

The New England journal of medicine, 2019-10, Vol.381 (16), p.1524-1534

2019

Volltextzugriff (PDF)

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

The Lancet (British edition), 2014-12, Vol.384 (9959), p.2027-2035

2014

Volltextzugriff (PDF)

Prostate-Cancer Mortality at 11 Years of Follow-up

The New England journal of medicine, 2012-03, Vol.366 (11), p.981-990

2012

Volltextzugriff (PDF)

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

European urology, 2012-11, Vol.62 (5), p.745-752

2012

Volltextzugriff (PDF)

Applicability and robustness of an artificial intelligence-based assessment for Greulich and Pyle bone age in a German cohort

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2024-06, Vol.196 (6), p.600

2024

Volltextzugriff (PDF)

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

The New England journal of medicine, 2008-05, Vol.358 (21), p.2205-2217

2008

Volltextzugriff (PDF)

A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)

BJU international, 2016-04, Vol.117 (4), p.576-583

2016

Volltextzugriff (PDF)

A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

European urology, 2015-10, Vol.68 (4), p.591-597

2015

Volltextzugriff (PDF)

Smart Multi-Frequency Bioelectrical Impedance Spectrometer for BIA and BIVA Applications

IEEE transactions on biomedical circuits and systems, 2016-08, Vol.10 (4), p.912-919

2016

Volltextzugriff (PDF)

Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer

European urology, 2012-04, Vol.61 (4), p.851-854

2012

Volltextzugriff (PDF)

Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort

BJU international, 2012-07, Vol.110 (2), p.195-200

2012

Volltextzugriff (PDF)

Stent Thrombosis and Bleeding Complications After Implantation of Sirolimus-Eluting Coronary Stents in an Unselected Worldwide Population: A Report From the e-SELECT (Multi-Center Post-Market Surveillance) Registry

Journal of the American College of Cardiology, 2011-03, Vol.57 (13), p.1445-1454

2011

Volltextzugriff (PDF)

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

Urologia internationalis, 2022-01, Vol.106 (1), p.83-89

2022

Volltextzugriff (PDF)

Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau)

International journal of cancer, 2015-08, Vol.137 (3), p.553-559

2015

Volltextzugriff (PDF)

Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

World journal of urology, 2015-08, Vol.33 (8), p.1189-1196

2015

Volltextzugriff (PDF)

Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

JNCI : Journal of the National Cancer Institute, 2017-04, Vol.109 (4)

2017

Volltextzugriff (PDF)

Outcomes following implantation of the biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry

Catheterization and cardiovascular interventions, 2015-12, Vol.86 (7), p.1151-1160

2015

Volltextzugriff (PDF)

Protocol-based Active Surveillance for Low-risk Prostate Cancer: Anxiety Levels in Both Men and Their Partners

Urology (Ridgewood, N.J.), 2012-09, Vol.80 (3), p.564-569

2012

Volltextzugriff (PDF)

1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial

JACC. Cardiovascular interventions, 2009-10, Vol.2 (10), p.909

2009

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library (Online service)

PublikationsformArtikel

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(30)

Sprache

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prostate cancer screening： and yet it moves

Screening and Prostate-Cancer Mortality in a Randomized European Study

Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial

Hydromethylthionine rescues synaptic SNARE proteins in a mouse model of tauopathies: Interference by cholinesterase inhibitors

Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

Prostate-Cancer Mortality at 11 Years of Follow-up

Screening for Prostate Cancer Decreases the Risk of Developing Metastatic Disease: Findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC)

Applicability and robustness of an artificial intelligence-based assessment for Greulich and Pyle bone age in a German cohort

Facilitated PCI in Patients with ST-Elevation Myocardial Infarction

A positive family history as a risk factor for prostate cancer in a population‐based study with organised prostate‐specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau)

A “PSA Pyramid” for Men with Initial Prostate-specific Antigen ≤3 ng/ml: A Plea for Individualized Prostate Cancer Screening

Smart Multi-Frequency Bioelectrical Impedance Spectrometer for BIA and BIVA Applications

Relationship Between Baseline Prostate-specific Antigen on Cancer Detection and Prostate Cancer Death: Long-term Follow-up from the European Randomized Study of Screening for Prostate Cancer

Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

Comment on the US Preventive Services Task Force's Draft Recommendation on Screening for Prostate Cancer

Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol‐based active surveillance: results from a contemporary European patient cohort

Stent Thrombosis and Bleeding Complications After Implantation of Sirolimus-Eluting Coronary Stents in an Unselected Worldwide Population: A Report From the e-SELECT (Multi-Center Post-Market Surveillance) Registry

Indication for Active Surveillance in the Era of MRI-Targeted Prostate Biopsies

Is further screening of men with baseline PSA < 1 ng ml(-1) worthwhile? The discussion continues-Results of the Swiss ERSPC (Aarau)

Influence of metformin use on PSA values, free-to-total PSA, prostate cancer incidence and grade and overall survival in a prospective screening trial (ERSPC Aarau)

Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

Outcomes following implantation of the biolimus A9-eluting BioMatrix coronary stent: Primary analysis of the e-BioMatrix registry

Protocol-based Active Surveillance for Low-risk Prostate Cancer: Anxiety Levels in Both Men and Their Partners

1-year survival in a randomized trial of facilitated reperfusion: results from the FINESSE (Facilitated Intervention with Enhanced Reperfusion Speed to Stop Events) trial

Aktive Filter

Suchergebnisse filtern